All News

It’s often hard to quantify, but angel investing is a growing around the world. New data indicate this will be key to overcoming the growth challenges facing entrepreneurs, says the OECD's Karen Wilson

Europe needs a fresh cycle of innovation to create a more “reactive economy” that can absorb shocks and bounce back, the European Education Commissioner Androulla Vassiliou tells the Science|Business European Entrepreneurship Summit

The EIT launches its first awards – ACES enters its fourth year. Start-ups from the UK and Germany lead the list of winners, which also includes Spanish and Hungarian companies.

US patent office offers patent examination at breakneck speed for a price

Alan Leshner, CEO of the American Association for the Advancement of Science, caused a stir at February’s EU ministerial conference in Copenhagen, with a hard-hitting speech on the state of US science. America's scientific eminence, 'is at risk' he said.

A private equity firm is to raise the largest specialist fund in the world dedicated to commercialising university R&D. The money will be invested in partnership with three of the UK’s leading research universities

The US patent office has released studies on international patenting and prior user defence, with other reports looking at the US patents scene to follow

Hard-pressed healthcare systems can no longer pay premium prices for new drugs. The consequence will be less innovation in Europe says Andrew Witty, CEO of GlaxoSmithKline.

In total, 8,900 small companies have won grants worth €2.4B

25 countries have agreed to back a single European research plan in neurodegenerative diseases. This is a defining moment for coordinated research says the Commissioner

The European Commission proposes to unite national funding agencies in ‘pacts’ to complete the European Research Area (ERA) by 2014 deadline - without further legislation

Only world-class science will deliver the innovation and growth Europe so desperately needs. US experience can help EU policy makers understand how to enhance R&D productivity and encourage excellence, says Paula Stephan

The $1,000 genome has arrived, providing the spur for personalised healthcare to move from theory to practice. Some existing examples of best practice and roadmaps for the future are pointing the way

Personalised healthcare promises long-term value. But how can Europe justify the upfront costs at a time of massive cuts in public spending?

Demand for fuel and power is set to keep rising strongly over the next two decades, led by the fast growing economies of China and India, projects BP